Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder

A technology of ultra-fine particles and hypoglycemic tablets, which is applied in the fields of metabolic diseases, drug combinations, and pharmaceutical formulas. It can solve problems such as limitations of drug efficacy, production and processing methods, inconsistent dosage forms of production processes, and difficulty in fully utilizing active ingredients of drugs. Achieve the effects of increasing C-peptide, reversing the decline trend of islet function, and enriching raw materials

Inactive Publication Date: 2011-07-06
谷井文
View PDF9 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although traditional Chinese medicine has a long history and irreplaceable advantages in treating diabetes, the traditional production and processing methods, production processes, dosage forms and dosages are not uniform, and it is difficult to fully utilize the active ingredients of the medicine, resulting in limited efficacy of the medicine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] Examples are detailed below

[0008] Take 105 grams of Nansha ginseng, 105 grams of Ophiopogon japonicus, 70 grams of Anemarrhena, 70 grams of raw land, 70 grams of dendrobium, 70 grams of gypsum, 70 grams of scutellaria, 14 grams of berberine, 70 grams of trichosanthin, 35 grams of schisandra, 70 grams of astragalus, and 70 grams of peony bark. gram, 70 grams of salvia miltiorrhiza, 21 grams of licorice. Take 35 grams of gypsum, 35 grams of Scutellaria baicalensis, 14 grams of Coptis chinensis, 35 grams of TCS, 35 grams of Astragalus membranaceus, 35 grams of Moutan cortex, and 35 grams of salvia miltiorrhiza from the above-mentioned drugs, and use a Bailey pulverizer to pulverize them into superfine powder for later use; add water to decoct the rest of the drugs Boil, add 8 times the amount of water for 2 hours for the first time, add 6 times the amount of water for 2 hours for the second time, combine the two medicinal liquids, filter, and concentrate the filtrate to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Chinese medicinal blood glucose reducing tablet for treating diabetes.. The Chinese medicinal blood glucose reducing tablet comprises superfine powder and is prepared from fourleaf ladybell root, dwarf lilyturf tuber, Common anemarrhena, rehmannia root, noble dendrobium stem herb, gypsum, baikal skullcap root, Chinese goldthread rhizome, snakegourd root, Chinese magnoliavine fruit, milkvetch root, moutan bark, dan-shen root and licorice root. The tablet is prepared from the following steps: taking half of each of gypsum, baikal skullcap root, snakegourd root, milkvetch root, moutan bark and dan-shen root, adding Chinese goldthread rhizome, pulverizing into superfine powder with beili pulverizer, decocting the rest raw materials with water twice, mixing decoctions, filtering, concentrating filtrate to thick extract with relative density of 1.25-1.30 (60-70 DEG C), adding superfine powder, and processing into tablets. The tablet is administered for 3 times every day, with 3-4 tablets per time. The Chinese medicinal blood glucose reducing tablet has low cost and is easy for preparation and convenient for administration, the raw materials are easily accessible, and the effective ingredients can dissolve out and be digested, absorbed and utilized to a maximum extent. The tablet has the effects of nourishing yin, moistening dryness, turning recession trend of islet functions, and promoting revivification of islet cells. In addition, through administration of the tablets, patients need not to suffer from the bitter taste of traditional decoction.

Description

technical field [0001] The invention relates to traditional Chinese medicine for oral administration, in particular to an ultrafine Chinese medicine Jiangtang tablet for treating diabetes. Background technique [0002] Diabetes is a clinical common disease and frequently-occurring disease. It is mainly caused by various factors such as genetics, immune dysfunction, microbial infection and its toxins, free radical toxins, and mental factors acting on the human body to cause hypofunction of the islets of the pancreas and the resistance of the islets. , protein, fat, water and electrolytes and a series of metabolic dysfunction syndrome. Clinically, hyperglycemia is the main feature. In typical cases, symptoms such as polyuria, polydipsia, polyphagia, and weight loss can be seen, that is, symptoms of "three excesses and one deficiency". Diabetes is divided into type I diabetes and type II diabetes. Type I diabetes is more common in adolescents, who rely on exogenous insulin s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8984A61K9/20A61P3/10A61K33/06
Inventor 谷井文
Owner 谷井文
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products